Abstract

Antiviral effectors such as Natural Killer (NK) cells have impaired functions in chronic hepatitis B (CHB) patients. The molecular mechanism responsible for this dysfunction remains poorly characterized. We show that decreased cytokine production capacity of peripheral NK cells from CHB patients was associated with reduced expression of NKp30 and CD16, and defective mTOR pathway activity. Transcriptome analysis of patients NK cells revealed an enrichment for transcripts expressed in exhausted T cells suggesting that NK cell dysfunction and T cell exhaustion employ common mechanisms. In particular, the transcription factor TOX and several of its targets were over-expressed in NK cells of CHB patients. This signature was predicted to be dependent on the calcium-associated transcription factor NFAT. Stimulation of the calcium-dependent pathway recapitulated features of NK cells from CHB patients. Thus, deregulated calcium signalling could be a central event in both T cell exhaustion and NK cell dysfunction occurring during chronic infections.

Data availability

Sequencing data have been deposited in GEO under accession codes GSE153946.

The following data sets were generated

Article and author information

Author details

  1. Marie Marotel

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Marine Villard

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Annabelle Drouillard

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Issam Tout

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Laurie Besson

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Omran Allatif

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Marine Pujol

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Yamila Rocca

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Michelle Ainouze

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Guillaume Roblot

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Sébastien Viel

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5085-443X
  12. Melissa Gomez

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Veronique Loustaud

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Sophie Alain

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  15. David Durantel

    Cancerology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  16. Thierry Walzer

    International Center for Infectiology Research (CIRI), Lyon, France
    For correspondence
    thierry.walzer@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0857-8179
  17. Uzma Hasan

    Immunology, Inserm, Lyon, France
    For correspondence
    uzma.hasan@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
  18. Antoine Marçais

    International Center for Infectiology Research (CIRI), Lyon, France
    For correspondence
    antoine.marcais@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3591-6268

Funding

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ22398)

  • Uzma Hasan

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ11169)

  • Uzma Hasan

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ19856)

  • Uzma Hasan

Agence Nationale de la Recherche (BaNK)

  • Antoine Marçais

Agence Nationale de la Recherche (SPHINKS)

  • Thierry Walzer

Association de Recherche sur le Cancer (Equipe labellisée)

  • Thierry Walzer

H2020 European Research Council (ERC-Stg 281025)

  • Thierry Walzer

La Ligue Nationale contre le Cancer (Graduate student fellowship)

  • Marie Marotel

La Ligue du Rhone (LNCC)

  • Uzma Hasan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: All participants provided written informed consent in accordance with the procedure approved by the local ethics committee (Comité de Protection des Personnes, Centre Hospitalier Universitaire de Limoges, Limoges, France) and the Interventional research protocol involving human samples (Code promotor LiNKeB project: 87RI18-0021).

Copyright

© 2021, Marotel et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,607
    views
  • 372
    downloads
  • 35
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marie Marotel
  2. Marine Villard
  3. Annabelle Drouillard
  4. Issam Tout
  5. Laurie Besson
  6. Omran Allatif
  7. Marine Pujol
  8. Yamila Rocca
  9. Michelle Ainouze
  10. Guillaume Roblot
  11. Sébastien Viel
  12. Melissa Gomez
  13. Veronique Loustaud
  14. Sophie Alain
  15. David Durantel
  16. Thierry Walzer
  17. Uzma Hasan
  18. Antoine Marçais
(2021)
Peripheral Natural Killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion
eLife 10:e60095.
https://doi.org/10.7554/eLife.60095

Share this article

https://doi.org/10.7554/eLife.60095

Further reading

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Malika Hale, Kennidy K Takehara ... Marion Pepper
    Research Article

    Pseudomonas aeruginosa (PA) is an opportunistic, frequently multidrug-resistant pathogen that can cause severe infections in hospitalized patients. Antibodies against the PA virulence factor, PcrV, protect from death and disease in a variety of animal models. However, clinical trials of PcrV-binding antibody-based products have thus far failed to demonstrate benefit. Prior candidates were derivations of antibodies identified using protein-immunized animal systems and required extensive engineering to optimize binding and/or reduce immunogenicity. Of note, PA infections are common in people with cystic fibrosis (pwCF), who are generally believed to mount normal adaptive immune responses. Here, we utilized a tetramer reagent to detect and isolate PcrV-specific B cells in pwCF and, via single-cell sorting and paired-chain sequencing, identified the B cell receptor (BCR) variable region sequences that confer PcrV-specificity. We derived multiple high affinity anti-PcrV monoclonal antibodies (mAbs) from PcrV-specific B cells across three donors, including mAbs that exhibit potent anti-PA activity in a murine pneumonia model. This robust strategy for mAb discovery expands what is known about PA-specific B cells in pwCF and yields novel mAbs with potential for future clinical use.

    1. Cell Biology
    2. Immunology and Inflammation
    Alejandro Rosell, Agata Adelajda Krygowska ... Esther Castellano Sanchez
    Research Article

    Macrophages are crucial in the body’s inflammatory response, with tightly regulated functions for optimal immune system performance. Our study reveals that the RAS–p110α signalling pathway, known for its involvement in various biological processes and tumourigenesis, regulates two vital aspects of the inflammatory response in macrophages: the initial monocyte movement and later-stage lysosomal function. Disrupting this pathway, either in a mouse model or through drug intervention, hampers the inflammatory response, leading to delayed resolution and the development of more severe acute inflammatory reactions in live models. This discovery uncovers a previously unknown role of the p110α isoform in immune regulation within macrophages, offering insight into the complex mechanisms governing their function during inflammation and opening new avenues for modulating inflammatory responses.